These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 2689773

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of cyclosporine on in situ immune complex glomerulonephritis.
    Thaiss F, Mihatsch MJ, Batsford S, Vogt A, Schollmeyer P.
    Clin Nephrol; 1986; 25 Suppl 1():S181-5. PubMed ID: 3519025
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme inhibition in experimental in-situ immune complex glomerulonephritis: influence on renal function, proteinuria, and morphology.
    Thaiss F, Haas C, Helmchen U, Wenzel U, Stahl RA.
    Nephrol Dial Transplant; 1996 Jan; 11(1):40-6. PubMed ID: 8649651
    [Abstract] [Full Text] [Related]

  • 4. Mediator systems in a passive model of in situ immune complex glomerulonephritis. Role for complement, polymorphonuclear granulocytes and monocytes.
    Thaiss F, Batsford S, Mihatsch MJ, Heitz PU, Bitter-Suermann D, Vogt A.
    Lab Invest; 1986 Jun; 54(6):624-35. PubMed ID: 2940417
    [Abstract] [Full Text] [Related]

  • 5. Complement and leukocyte independent proteinuria and eicosanoid synthesis in rat membranous nephropathy.
    Rahman MA, Liu CN, Dunn MJ, Emancipator SN.
    Lab Invest; 1988 Oct; 59(4):477-83. PubMed ID: 3050273
    [Abstract] [Full Text] [Related]

  • 6. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP, Tramontano A.
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporin reduces proteinuria in rats with aminonucleoside nephrosis.
    Kokui K, Yoshikawa N, Nakamura H, Itoh H.
    J Pathol; 1992 Mar; 166(3):297-301. PubMed ID: 1517884
    [Abstract] [Full Text] [Related]

  • 8. Effect of antiproteolytic drugs: epsilon-aminocaproic acid (EACA) and aprotinin on experimental anti-GBM nephritis.
    Hruby Z, Wendycz D, Kopeć W, Czerchawski L, Józefowiak M, Rabczyński J.
    Nephrol Dial Transplant; 1996 Jan; 11(1):32-9. PubMed ID: 8649650
    [Abstract] [Full Text] [Related]

  • 9. The effect of protamine sulfate on the course of immune complex glomerulonephritis in the rat.
    Oite T, Shimizu F, Batsford SR, Vogt A.
    Clin Exp Immunol; 1986 May; 64(2):318-22. PubMed ID: 2943540
    [Abstract] [Full Text] [Related]

  • 10. Effect of cyclosporin on immune complex deposition in murine glomerulonephritis.
    Quinn DG, Fennell JS, Sheils O, Gaffney EF, Feighery CF.
    Immunology; 1991 Apr; 72(4):550-4. PubMed ID: 1828056
    [Abstract] [Full Text] [Related]

  • 11. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.
    Hoyer JR, Mauer SM, Michael AF.
    J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713
    [Abstract] [Full Text] [Related]

  • 12. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M, Schulze M, Exner M, Kerjaschki D.
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hydroxyl radical scavengers ameliorate proteinuria in rat immune complex glomerulonephritis.
    Rahman MA, Emancipator SS, Sedor JR.
    J Lab Clin Med; 1988 Nov; 112(5):619-26. PubMed ID: 2460571
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T, Cybulsky AV, Cupples WA, Ajikobi DO, Papillon J, Aoudjit L.
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [Abstract] [Full Text] [Related]

  • 16. Mesangial glomerulonephropathy with deposition of IgG, IgM, and C3 induced by mercuric chloride: a new model.
    Makker SP, Aikawa M.
    Lab Invest; 1979 Jul; 41(1):45-50. PubMed ID: 376939
    [Abstract] [Full Text] [Related]

  • 17. Effect of alterations in glomerular charge on deposition of cationic and anionic antibodies to fixed glomerular antigens in the rat.
    Adler S, Baker P, Pritzl P, Couser WG.
    J Lab Clin Med; 1985 Jul; 106(1):1-11. PubMed ID: 3891891
    [Abstract] [Full Text] [Related]

  • 18. Mechanism of formation of subepithelial electron-dense deposits in active in situ immune complex glomerulonephritis.
    Kagami S, Kawakami K, Okada K, Kuroda Y, Morioka T, Shimizu F, Oite T.
    Am J Pathol; 1990 Mar; 136(3):631-9. PubMed ID: 1690511
    [Abstract] [Full Text] [Related]

  • 19. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Mar; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 20. The heterologous immune complex glomerulonephritis. A dose dependent glomerulonephritis with acute, latent and chronic phases in a long-term study.
    Iversen BM, Matre R, Ofstad J.
    Acta Pathol Microbiol Immunol Scand C; 1982 Oct; 90(5):241-50. PubMed ID: 6217719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.